Back to search

Article

Enhanced Loading of Paclitaxel in Cationic Liposomes by Replacement of Oleoyl with Linoleoyl Lipid Tails with Benefits in Cancer Therapeutics from <i>In Vitro</i> Studies

2020-10-12

Abstract excerpt

Lipid-based carriers of the hydrophobic drug paclitaxel (PTX) are used in clinical trials as next-generation agents for cancer chemotherapy. Improving the loading capacity of these carriers requires enhanced PTX solubilization. We compared the solubility of PTX in cationic liposomes (CLs) with lipid tails containing one (oleoyl; C18:1 Δ 9 ; DOTAP/DOPC) or two (linoleoyl; C18:2 Δ 9 ; DLinTAP/DLinPC) cis double b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9abc09a0-971a-5955-a02c-3ca7d4c9891e
DOI
10.1101/2020.10.12.336412
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhanced Loading of Paclitaxel in Cationic Liposomes by Replacement of Oleoyl with Linoleoyl Lipid Tails with Benefits in Cancer Therapeutics from <i>In Vitro</i> StudiesDOI 10.1101/2020.10.12.336412
Select a neighboring publication to make it the new centre.